187 related articles for article (PubMed ID: 29052674)
1. EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy.
Jin H; Pi J; Zhao Y; Jiang J; Li T; Zeng X; Yang P; Evans CE; Cai J
Nanoscale; 2017 Nov; 9(42):16365-16374. PubMed ID: 29052674
[TBL] [Abstract][Full Text] [Related]
2. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer.
Mukerjee A; Ranjan AP; Vishwanatha JK
J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533
[TBL] [Abstract][Full Text] [Related]
3. GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells.
Li K; Pang L; Pan X; Fan S; Wang X; Wang Q; Dai P; Gao W; Gao J
Technol Cancer Res Treat; 2021; 20():15330338211004954. PubMed ID: 34056977
[TBL] [Abstract][Full Text] [Related]
4. GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma.
Borah A; Pillai SC; Rochani AK; Palaninathan V; Nakajima Y; Maekawa T; Kumar DS
Nanotechnology; 2020 May; 31(18):185102. PubMed ID: 31952056
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
Cui T; Zhang S; Sun H
Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Antitumor Efficacy of Curcumin-Loaded PLGA Nanoparticles Coated with Unique Fungal Hydrophobin.
Sun L; Xu H; Xu JH; Wang SN; Wang JW; Zhang HF; Jia WR; Li LS
AAPS PharmSciTech; 2020 Jun; 21(5):171. PubMed ID: 32529560
[TBL] [Abstract][Full Text] [Related]
7. The remarkable role of emulsifier and chitosan, dextran and PEG as capping agents in the enhanced delivery of curcumin by nanoparticles in breast cancer cells.
Sampath M; Pichaimani A; Kumpati P; Sengottuvelan B
Int J Biol Macromol; 2020 Nov; 162():748-761. PubMed ID: 32585267
[TBL] [Abstract][Full Text] [Related]
8. Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation.
Huo ZJ; Wang SJ; Wang ZQ; Zuo WS; Liu P; Pang B; Liu K
Cancer Sci; 2015 Oct; 106(10):1429-37. PubMed ID: 26177628
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive efficacy of curcumin-loaded PLGA microparticles in a transgenic mouse model of HER-2-positive breast cancer.
Grill AE; Shahani K; Koniar B; Panyam J
Drug Deliv Transl Res; 2018 Apr; 8(2):329-341. PubMed ID: 28417445
[TBL] [Abstract][Full Text] [Related]
10. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
Huo X; Zhang Y; Jin X; Li Y; Zhang L
J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
[TBL] [Abstract][Full Text] [Related]
11. Anti-EGFR anchored paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities.
Venugopal V; Krishnan S; Palanimuthu VR; Sankarankutty S; Kalaimani JK; Karupiah S; Kit NS; Hock TT
PLoS One; 2018; 13(11):e0206109. PubMed ID: 30408068
[TBL] [Abstract][Full Text] [Related]
12. Microfluidic Assisted Nanoprecipitation of PLGA Nanoparticles for Curcumin Delivery to Leukemia Jurkat Cells.
Leung MHM; Shen AQ
Langmuir; 2018 Apr; 34(13):3961-3970. PubMed ID: 29544247
[TBL] [Abstract][Full Text] [Related]
13. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
Thamake SI; Raut SL; Gryczynski Z; Ranjan AP; Vishwanatha JK
Biomaterials; 2012 Oct; 33(29):7164-73. PubMed ID: 22795543
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
15. Dual-Targeting Magnetic PLGA Nanoparticles for Codelivery of Paclitaxel and Curcumin for Brain Tumor Therapy.
Cui Y; Zhang M; Zeng F; Jin H; Xu Q; Huang Y
ACS Appl Mater Interfaces; 2016 Nov; 8(47):32159-32169. PubMed ID: 27808492
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine Co-Encapsulated with Curcumin in Folate Decorated PLGA Nanoparticles; a Novel Approach to Treat Breast Adenocarcinoma.
Mukhopadhyay R; Sen R; Paul B; Kazi J; Ganguly S; Debnath MC
Pharm Res; 2020 Feb; 37(3):56. PubMed ID: 32072346
[TBL] [Abstract][Full Text] [Related]
17. Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.
He Z; Shi Z; Sun W; Ma J; Xia J; Zhang X; Chen W; Huang J
Tumour Biol; 2016 Jun; 37(6):7809-21. PubMed ID: 26695149
[TBL] [Abstract][Full Text] [Related]
18. Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A).
Khan MN; Haggag YA; Lane ME; McCarron PA; Tambuwala MM
Curr Drug Deliv; 2018 Feb; 15(2):286-295. PubMed ID: 29065834
[TBL] [Abstract][Full Text] [Related]
19. Levan enhanced the NF-κB suppression activity of an oral nano PLGA-curcumin formulation in breast cancer treatment.
Eskandari Z; Bahadori F; Yenigun VB; Demiray M; Eroğlu MS; Kocyigit A; Oner ET
Int J Biol Macromol; 2021 Oct; 189():223-231. PubMed ID: 34419542
[TBL] [Abstract][Full Text] [Related]
20. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line.
Tabatabaei Mirakabad FS; Akbarzadeh A; Milani M; Zarghami N; Taheri-Anganeh M; Zeighamian V; Badrzadeh F; Rahmati-Yamchi M
Artif Cells Nanomed Biotechnol; 2016; 44(1):423-30. PubMed ID: 25229832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]